| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/1993 | US5216124 Analgesics |
| 06/01/1993 | US5215969 Dopaminergic neurotrophic factor for treatment of Parkinson's disease |
| 06/01/1993 | US5215967 Aminoacid derivatives inhibiting renin |
| 06/01/1993 | US5215966 For treatment of hypertension, hyperaldosteronism and cardiac insufficiency |
| 06/01/1993 | US5215964 Treating aging, depression, anxiety, autoimmune diseases |
| 06/01/1993 | US5215963 Solubilization and purification of the active gastrin releasing peptide receptor |
| 06/01/1993 | US5215917 Nucleotide sequence encoding the Toxoplasma gondii P22 gene |
| 06/01/1993 | US5215916 Super glucocorticoid receptors: receptors with increased affinity and specificity for glucocorticoid steriods |
| 06/01/1993 | US5215915 Cloned gene encoding rat d1b dopamine receptor |
| 06/01/1993 | US5215914 Adherent and invasive mycoplasma |
| 06/01/1993 | US5215912 Monocot seed storage proteins in dicots |
| 06/01/1993 | US5215898 Cytotoxic protein from the yeast Pichia inositovora |
| 06/01/1993 | US5215896 Leader sequences for the production of recombinant proteins |
| 06/01/1993 | US5215895 Dna encoding a mammalian cytokine, interleukin-11 |
| 06/01/1993 | US5215893 Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 06/01/1993 | US5215892 C/EBP2 gene and recombinant C/EBP2 |
| 06/01/1993 | US5215889 Catalytic and reactive polypeptides and methods for their preparation and use |
| 06/01/1993 | US5215888 Kit for assaying the cellular integrity of blood platelets |
| 06/01/1993 | US5215881 Pseudorabies diagnosis probes |
| 06/01/1993 | CA1318619C Method of using eukaryotic expression vectors comprising the bk virus enhancer |
| 06/01/1993 | CA1318617C Enhanced secretion of heterologous proteins by hosts using substituted promoters |
| 06/01/1993 | CA1318616C Repressible yeast promoters |
| 06/01/1993 | CA1318615C Radiohalogenated compounds for site specific labeling |
| 06/01/1993 | CA1318614C Single vial technique for radio-labeling protein |
| 05/28/1993 | CA2083529A1 Plasmid phky334, an expression vector for ek-bgh and host cells transformed therewith |
| 05/27/1993 | WO1993010260A1 Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases |
| 05/27/1993 | WO1993010251A1 A method for obtaining plants with reduced susceptibility to plant-parasitic nematodes |
| 05/27/1993 | WO1993010250A1 Transcription adaptors in eukaryotes |
| 05/27/1993 | WO1993010247A1 PHASMID VECTOR IN $i(E.COLI) |
| 05/27/1993 | WO1993010246A1 Membrane expression of heterologous genes |
| 05/27/1993 | WO1993010242A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 05/27/1993 | WO1993010239A2 Hepatitis-c virus testing |
| 05/27/1993 | WO1993010238A1 Pneumococcal fimbrial protein a vaccines |
| 05/27/1993 | WO1993010237A1 Recombinant vaccine against lyme disease |
| 05/27/1993 | WO1993010236A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | WO1993010235A1 Human il-4 mutant proteins |
| 05/27/1993 | WO1993010234A1 Therapy of central nervous system by genetically modified cells |
| 05/27/1993 | WO1993010233A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
| 05/27/1993 | WO1993010232A1 Lymphoid cd30-antigen |
| 05/27/1993 | WO1993010231A1 Collagen-like polypeptides |
| 05/27/1993 | WO1993010230A1 Ligand-stimulated gene expression |
| 05/27/1993 | WO1993010229A1 Fusion proteins comprising mgf and il-3 |
| 05/27/1993 | WO1993010228A1 Dna encoding a glycine transporter and uses thereof |
| 05/27/1993 | WO1993010227A1 Transgenic animals lacking prion proteins |
| 05/27/1993 | WO1993010220A1 Soluble mhc molecules and their uses |
| 05/27/1993 | WO1993010215A1 Purified proteoglycan betaglycan, compositions, and methods |
| 05/27/1993 | WO1993010214A1 Expression of proteins on bacterial surface |
| 05/27/1993 | WO1993010155A1 6(r)-l-erythro-5,6,7,8-tetrahydrobiopterin receptor |
| 05/27/1993 | WO1993010154A1 High molecular weight collagen-like protein polymers |
| 05/27/1993 | WO1993010153A1 Bactericidal product, pharmaceutical composition containing same and food additive |
| 05/27/1993 | WO1993010152A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
| 05/27/1993 | WO1993010151A1 Receptor for oncostatin m and leukemia inhibitory factor |
| 05/27/1993 | WO1993010150A1 Expression of neurotrophic factors with heterologous prepro regions |
| 05/27/1993 | WO1993010149A1 Recombinant mammalian calcitonin receptors and uses thereof |
| 05/27/1993 | WO1993010146A1 Amylin agonist peptides and uses therefor |
| 05/27/1993 | WO1993010145A1 Compositions for delayed treatment of ischemia-related neuronal damage |
| 05/27/1993 | WO1993010143A1 Antihemophilic factor stabilization |
| 05/27/1993 | WO1993010136A1 Totipotent hematopoietic stem cell receptors and their ligands |
| 05/27/1993 | WO1993010135A1 Characterization of estrogen responsive mouse lactoferrin promoter |
| 05/27/1993 | WO1993009869A1 Adsorbent for blood coagulation factor viii |
| 05/27/1993 | WO1993009816A1 Method for diagnosing and treating cancer |
| 05/27/1993 | WO1993009815A1 Specific tolerance in transplantation |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009811A1 TYPE I AND TYPE II SURFACE ANTIGENS ASSOCIATED WITH $i(STAPHYLOCOCCUS EPIDERMIDIS) |
| 05/27/1993 | WO1993009810A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | WO1993009808A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R |
| 05/27/1993 | WO1993009806A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
| 05/27/1993 | WO1993009804A1 Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation |
| 05/27/1993 | WO1993009800A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 05/27/1993 | WO1993009799A1 Suppression of megakaryocytopoiesis by macrophage inflammatory proteins |
| 05/27/1993 | WO1993009798A1 Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding |
| 05/27/1993 | WO1993009794A1 Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 |
| 05/27/1993 | WO1993009790A1 Methods of inhibiting restenosis |
| 05/27/1993 | WO1993009668A1 Combinatorial strategies for polymer synthesis |
| 05/27/1993 | WO1993006218A3 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines |
| 05/27/1993 | WO1993004172A3 Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula |
| 05/27/1993 | WO1993003058A3 Non-desensitizing analogs of gnrh and other biologically active ligands |
| 05/27/1993 | WO1993001820A3 Inhibition of non-cd4 mediated hiv infection |
| 05/27/1993 | DE4238806A1 Methicillin-resistant staphylococcus aureus (MRSA)detection method - by detection of MRSA penicillin binding protein (PBP)2 antigen-antibody complex, and synthetic MRSA PBP2 peptides |
| 05/27/1993 | DE4209110A1 Neue thrombininhibitorische proteine aus landblutegeln Country leeches novel thrombin proteins from |
| 05/27/1993 | DE4138341C1 DNA molecule for genetic pre-disposition detection to multi-endocrine neoplasia - comprises genomic cloned beta-DNA sequence and fragments in human chromosome, for hybridisation technique and selective cleavage with restriction enzymes |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2124857A1 Methods of inhibiting restenosis |
| 05/27/1993 | CA2123906A1 Transcription adaptors in eukaryotes |
| 05/27/1993 | CA2123874A1 Methods for detecting and isolating upa-r and inhibiting the binding of upa to upa-r |
| 05/27/1993 | CA2123676A1 Expression of proteins on bacterial surface |
| 05/27/1993 | CA2123675A1 Membrane expression of heterologous genes |
| 05/27/1993 | CA2123588A1 Method for diagnosing and treating cancer |
| 05/27/1993 | CA2123587A1 Bactericide product; pharmaceutical composition and food additive containing the same |
| 05/27/1993 | CA2123582A1 Recombinant mammalian calcitonin receptors and uses thereof |
| 05/27/1993 | CA2123418A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 05/27/1993 | CA2123323A1 Dna encoding a glycine transporter and uses thereof |
| 05/27/1993 | CA2123316A1 High molecular weight collagen-like protein polymers |
| 05/27/1993 | CA2123234A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
| 05/27/1993 | CA2123228A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | CA2123210A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | CA2123121A1 Recombinant vaccine against lyme disease |
| 05/27/1993 | CA2121578A1 A method for obtaining plants with reduced susceptibility to plant-parasitic nematodes |
| 05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |
| 05/27/1993 | CA2083360A1 Tri-arginine insulins |